Page last updated: 2024-10-26

disopyramide and Atrial Septal Defect

disopyramide has been researched along with Atrial Septal Defect in 1 studies

Disopyramide: A class I anti-arrhythmic agent (one that interferes directly with the depolarization of the cardiac membrane and thus serves as a membrane-stabilizing agent) with a depressant action on the heart similar to that of guanidine. It also possesses some anticholinergic and local anesthetic properties.
disopyramide : A monocarboxylic acid amide that is butanamide substituted by a diisopropylamino group at position 4, a phenyl group at position 2 and a pyridin-2-yl group at position 2. It is used as a anti-arrhythmia drug.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Chen, F1
Hanaoka, N1
Hasegawa, S1
Fujinaga, T1
Shoji, T1
Sakai, H1
Bando, T1

Other Studies

1 other study available for disopyramide and Atrial Septal Defect

ArticleYear
Right ventricular outflow tract obstruction after bilateral lung transplantation.
    The Thoracic and cardiovascular surgeon, 2009, Volume: 57, Issue:1

    Topics: Adult; Atenolol; Cardiac Surgical Procedures; Cardiovascular Agents; Disopyramide; Drug Therapy, Com

2009